Home > News > News infomation
Announcement on Special Review for the Applications of Innovative Medical Devices and Priority Approval (2019 No. 7-9)
2019-07-03 14:43

China NMPA announced the following enterprises whose applications fully comply with the prerequisite criteria and are accepted into the special review process of innovative medical device and priority review of medical device, respectively.


Approved Applications for Special Review of Innovative Medical Devices

Product name: Self-expandable Aneurysm Embolization System (自膨式动脉瘤瘤内栓塞系统)
Applicant: Sequent Medical, Inc.

Product name: Oxidized Regenerated Cellulose Hemostatic Powder (再生氧化纤维素可吸收止血粉)
Applicant: Ethicon LLC

Product name:  Cardiac cryoablation system (心脏冷冻消融系统)
Applicant: Kangfeng Biotechnology (Shanghai) Co., Ltd

Product name: Aortic Stent Graft System (主动脉覆膜支架破膜系统) Applicant: LifeTech Scientific (Shenzhen) Limited Company



Approved Applications for the Priority Review of Medical Devices

CodeProduct nameApplicantApproved reason

Hepatitis B virus pgRNA (HBV-pgRNA) assay kit (PCR-fluorescence probe method)


Hotgen Biotech Co.,Ltd


This medical device is listed and included as the national science and technology major projects.
CSZ1900199Newborn screening for non-derivative multiple genetic metabolic diseases (tandem mass spectrometry)

Suzhou Sym-Bio Life Science Co.,Ltd.


This medical device is used to treat rare disease, and clearly demonstrate clinical benefits


Published on Jun 28, 2019

Company Profile
Our services
Contact us
+49 30 5059 0627+49 30 8186 5124
Copyright © 2023 Osmunda Medical Device Service Group              粤ICP备05082100号-3